On 25 January 2017
Alembic Pharmaceuticals announced that a Meeting of Board of Directors of the Company shall be held on 25 January 2017, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months period ended on 31 December 2016 (Q3).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content